Showing results (21-30 of 114) with videos related to
Sort By:
Pageof 12
Psychopharmacology|September 21, 2007
Evaluation of cannabinoid agonists using punished responding and midazolam discrimination procedures in squirrel monkeysMarcus S Delatte, Carol A ParonisBehavioural Pharmacology|March 15, 2022
Altered sleep during spontaneous cannabinoid withdrawal in male miceGalen Missig, Niyati Mehta, James O Robbins, et al.Psychological Bulletin|April 17, 2003
Smoking, stress, and negative affect: correlation, causation, and context across stages of smokingJon D Kassel, Laura R Stroud, Carol A ParonisExperimental and Clinical Psychopharmacology|December 18, 2008
Medications for stimulant abuse: agonist-based strategies and preclinical evaluation of the mixed-action D-sub-2 partial agonist aripiprazole (Abilify)Jack BergmanBehavioural Pharmacology|October 19, 2012
Δ(9)-Tetrahydrocannabinol acts as a partial agonist/antagonist in miceCarol A Paronis, Spyros P Nikas, Vidyanand G Shukla, et al.Journal of Medicinal Chemistry|July 2, 2016
Novel C-Ring-Hydroxy-Substituted Controlled Deactivation Cannabinergic AnaloguesShashank Kulkarni, Spyros P Nikas, Rishi Sharma, et al.Drug and Alcohol Dependence|December 27, 2023
Effects of inhaled low-concentration xenon gas on naltrexone-precipitated withdrawal symptoms in morphine-dependent miceMarc J Kaufman, Edward G Meloni, Alaa N Qrareya, et al.Molecules (Basel, Switzerland)|October 14, 2022
A Journey through Diastereomeric Space: The Design, Synthesis, In Vitro and In Vivo Pharmacological Activity, and Molecular Modeling of Novel Potent Diastereomeric MOR Agonists and AntagonistsDana R Chambers, Agnieszka Sulima, Dan Luo, et al.Molecules (Basel, Switzerland)|June 28, 2023
Discovery of a Potent Highly Biased MOR Partial Agonist among Diastereomeric C9-Hydroxyalkyl-5-phenylmorphansJoshua A Lutz, Agnieszka Sulima, Eugene S Gutman, et al.Psychopharmacology|November 22, 2018
Cannabinoid-induced lower lip retraction in ratsGirish R Chopda, Spyros P Nikas, Rishi Sharma, et al.Pageof 12